The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 95.80
Bid: 96.15
Ask: 96.25
Change: -1.20 (-1.24%)
Spread: 0.10 (0.104%)
Open: 97.20
High: 97.65
Low: 95.80
Prev. Close: 97.00
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 15:30

RNS Number : 8737F
Primary Health Properties PLC
06 March 2024
 

Primary Health Properties PLC

Director's & PDMR Dealings - LTIP Vesting

Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investors in modern primary healthcare facilities, announces that Richard Howell, Chief Financial Officer, together with certain other persons discharging managerial responsibility ("PDMRs") and employees have received Ordinary Shares of 12.5 pence each in the Company ("Ordinary Shares") under the terms of the Company's Long-Term Incentive Plan ("LTIP") (the "Vesting").

The awards vested on 6 March 2024 for nil consideration pursuant to a conditional award made on 12 May 2021. For Mr Bateman and Mr Austin, the number of Ordinary Shares which vested is stated after the deduction of the relevant taxation and National Insurance charges. No such deduction applies for Mr Howell, by whom relevant taxation and National Insurance charges will be paid separately.

Director

Number of shares vesting

Richard Howell

25,081

PDMR

David Bateman

7,144

David Austin

3,072

 

All Ordinary Shares in connection with the Vesting will be transferred to the relevant individuals from the Company's employee benefit trust ("EBT"), save for those to which Mr Howell is entitled, which will be retained in the EBT for a further two years under deferred payment arrangements relating to him.

Details of the operation of the LTIP are set out in the Company's 2022 Report and Accounts.

Details of the transactions referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1

Details of the person discharging managerial responsibilities/persons closely associated

(a)

Name

Richard Howell

 

2

Reason for notification

(a)

Position/Status

Chief Financial Officer

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Vesting of conditional share awards under the Company's LTIP

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

25,081

(d)

Aggregated Information

Single transaction: N/A

(e)

Date of transaction

6 March 2024

 

(f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities/persons closely associated

(a)

Name

David Bateman

 

2

Reason for notification

(a)

Position/Status

PDMR

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Vesting of conditional share awards under the Company's LTIP and transfer of Ordinary Shares to the PDMR

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

7,144

 

(d)

Aggregated Information

Single transaction: N/A

(e)

Date of transaction

6 March 2024

 

(f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

David Austin

 

2

Reason for notification

(a)

Position/Status

PDMR

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Vesting of conditional share awards under the Company's LTIP and transfer of Ordinary Shares to the PDMR

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

3,072

 

(d)

Aggregated Information

Single transaction: N/A

(e)

Date of transaction

6 March 2024

 

(f)

Place of transaction

London Stock Exchange (XLON)

 

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

 

Further details for enquiries:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344768

Steven Owen

Chairman

Tel: +44 (0) 203 8241 841

Richard Howell

Chief Financial Officer

Tel: +44 (0) 7766 072272

David Rydell / Stephanie Whitmore (Buchanan Communications)

Tel: +44 (0) 20 7466 5066

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDXLUGDGSL
Date   Source Headline
20th Jun 20237:00 amRNSNotice of Interim Results
19th Jun 20233:26 pmRNSDirector/PDMR Shareholding
19th Jun 20233:23 pmRNSDirector/PDMR Shareholding
14th Jun 20239:26 amRNSHolding(s) in Company
22nd May 20239:47 amRNSDirector/PDMR Shareholding
15th May 20239:18 amRNSDirector/PDMR Shareholding
26th Apr 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20233:58 pmRNSDirector/PDMR Shareholding
19th Apr 20233:23 pmRNSAGM Statement
19th Apr 20237:00 amRNSQ1 2023 Trading Update
11th Apr 20232:46 pmRNSDirector/PDMR Shareholding
11th Apr 20232:44 pmRNSDirector/PDMR Shareholding
6th Apr 202311:14 amRNSDirector’s & PDMR dealings
31st Mar 20239:20 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSNotice of Interim Dividend
15th Mar 20233:44 pmRNSDirector/PDMR Shareholding
15th Mar 20233:41 pmRNSDirector/PDMR Shareholding
15th Mar 202310:29 amRNSDirector/PDMR Shareholding
15th Mar 20238:39 amRNSAnnual Financial Report
14th Mar 202312:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:23 amRNSHolding(s) in Company
1st Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20238:59 amRNSCompany Secretary Change
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
27th Feb 20234:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSPreliminary Results
16th Feb 202311:38 amRNSHolding(s) in Company
8th Feb 202310:07 amRNSHolding(s) in Company
1st Feb 20239:40 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSAcquisition
16th Jan 20237:00 amRNSNotice of Preliminary Results
5th Jan 20237:00 amRNSDividend Declaration
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
15th Dec 20229:56 amEQSProactive Research Analyst Manos Halicioglu looks at Primary Health Properties
12th Dec 20227:00 amRNSSuccession Planning
6th Dec 20223:10 pmRNSHolding(s) in Company
30th Nov 202211:55 amRNSDirector/PDMR Shareholding
25th Nov 20222:19 pmRNSHolding(s) in Company
10th Nov 202210:30 amRNSDirector/PDMR Shareholding
7th Nov 202211:07 amRNSAppointment of joint broker
21st Oct 202212:01 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
20th Oct 20224:39 pmRNSHolding(s) in Company
13th Oct 20225:00 pmRNSConvertible Bond Adjustment
6th Oct 20227:00 amRNSDividend Declaration
27th Sep 20227:00 amRNSValue Creation Award Win
14th Sep 20225:36 pmRNSDirector/PDMR Shareholding
14th Sep 20225:33 pmRNSDirector/PDMR Shareholding
12th Sep 202212:06 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.